Chang, Ke;
Chen, Hua;
Chen, Yaxin;
Feng, Xiaochun;
Gao, Jian;
Gao, Xiuan;
Hu, Ziteng;
Li, Jijun;
Li, Min;
Li, Xinmin;
Liang, Ning;
Ming, Xi;
Qin, Yanhong;
Wang, Lining;
Wang, Xuefeng;
Wu, Liqun;
Yan, Lijiao;
Yang, Yijiu;
Zhang, Baoqing;
Zhang, Xuefei;
Zhang, Yujing.
Children are highly susceptible to influenza and are at high risk for severe cases. Chinese patent medicine (CPM) offers advantages in treating pediatric influenza, but the issue of its improper use is increasingly prevalent in clinical practice. To address this, we adopted a dual leadership approach inv...
Wu, Lei;
Chen, Yaolong;
Ma, Yanfang;
Yang, Zifeng;
Yang, Nan;
Denga, Wenze;
Chen, Yuanbin;
Sun, Yuanyuan;
Li, Yimin;
Lin, Lin.
Influenza is a major public health problem worldwide. Mutations and resistance development make the use of antiviral therapy challenging. Chinese patent medicines are often used to treat influenza in China and well tolerable. However, the misuse of Chinese patent medicines is common. We therefore aimed t...
Influenza, Human/prevention & control,
Influenza, Human/drug therapy,
Evidence-Based Pharmacy Practice,
Medicine, Chinese Traditional,
Patent,
Antiviral Agents/therapeutic use,
Oseltamivir/therapeutic use,
Phytotherapeutic Drugs
With increasing morbidity and mortality, acute myocardial infarction (AMI) has become one of the major causes of human death, leading to heavy burdens to individuals, families and society. Previous researches have found that though large amount of resources and great effort were devoted, no significant i...
